• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童生长障碍和关节运动范围受限应引起对黏多糖贮积症衰减形式的怀疑:专家意见。

Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion.

机构信息

Reference center of Inherited Metabolic disorder, CERLYMM, Département de Pédiatrie, HCL Hopital Femme Mère Enfant, 59 Boulevard Pinel, 69677, Bron cedex, France.

Paediatric Orthopaedic Surgery Department, Lorraine University Hospital Centre, Children's Hospital, Vandoeuvre lès Nancy, France.

出版信息

Eur J Pediatr. 2019 Apr;178(4):593-603. doi: 10.1007/s00431-019-03330-x. Epub 2019 Feb 11.

DOI:10.1007/s00431-019-03330-x
PMID:30740618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6438949/
Abstract

Growth impairment together with bone and joint involvement is common to most patients with mucopolysaccharidosis (MPS) disorders. The genetic basis for these metabolic disorders involves various enzyme deficiencies responsible for the catabolism of glycosaminoglycans (GAGs). The incomplete degradation and subsequent accumulation of GAGs result in progressive tissue damage throughout the body. Bone ossification is particularly affected, with the consequent onset of dysostosis multiplex which is the underlying cause of short stature. Joint manifestations, whether joint contractures (MPS I, II, VI, VII) or hyperlaxity (MPS IV), affect fine motor skills and quality of life. Subtle decreases in growth velocity can begin as early as 2-4 years of age. Pediatricians are in the front line to recognize or suspect MPS. However, given the rarity of the disorders and variable ages of symptom onset depending on disease severity, recognition and diagnostic delays remain a challenge, especially for the attenuated forms. Prompt diagnosis and treatment can prevent irreversible disease outcomes.Conclusion: We present a diagnostic algorithm based on growth velocity decline and bone and joint involvement designed to help pediatricians recognize early manifestations of attenuated forms of MPS. We illustrate the paper with examples of abnormal growth curves and subtle radiographic nuances. What is Known: • As mucopolysaccharidoses (MPSs) are rare genetic disorders infrequently seen in clinical practice, there can be a lag between symptom onset and diagnosis, especially of attenuated forms of the disease. • This highlights the need for increased disease awareness to recognize early clinical signs and subsequently initiate early treatment to improve outcomes (normal height potential) and possibly prevent or delay the development of irreversible disease manifestations. What is New: • Growth impairment co-presenting with limited range of joint motion and radiographic anomalies in children should raise suspicions of possible attenuated MPS (AMPS). • Experts present a diagnostic algorithm with detailed focus on the decline in growth velocity, delayed puberty and limitation in joint mobility seen in children with AMPS, to shorten time-to-diagnosis and treatment and potentially improve patient outcome.

摘要

生长障碍以及骨骼和关节受累是大多数黏多糖贮积症(MPS)患者的共同特征。这些代谢紊乱的遗传基础涉及各种负责糖胺聚糖(GAG)分解代谢的酶缺乏。GAG 不完全降解和随后的积累导致全身组织逐渐受损。骨骼的骨化特别受到影响,随之而来的是多发性发育不良的发生,这是身材矮小的根本原因。关节表现,无论是关节挛缩(MPS I、II、VI、VII)还是过度松弛(MPS IV),都会影响精细运动技能和生活质量。生长速度的细微下降可能早在 2-4 岁时就开始出现。儿科医生处于识别或怀疑 MPS 的第一线。然而,由于这些疾病的罕见性以及症状发作的年龄因疾病严重程度而异,因此识别和诊断延迟仍然是一个挑战,尤其是对于轻度形式。及时诊断和治疗可以预防不可逆转的疾病结局。结论:我们提出了一种基于生长速度下降和骨骼关节受累的诊断算法,旨在帮助儿科医生识别 MPS 轻度形式的早期表现。我们用异常生长曲线和细微的放射学细微差别来说明本文。已知的是:• 由于黏多糖贮积症(MPS)是罕见的遗传疾病,在临床实践中很少见,因此从症状发作到诊断可能存在时间滞后,尤其是对于疾病的轻度形式。• 这强调了需要提高疾病意识,以识别早期临床体征,随后尽早开始治疗,以改善结果(正常身高潜力),并可能预防或延迟不可逆疾病表现的发展。新的是:• 儿童出现生长障碍,伴有关节活动范围有限和放射学异常,应怀疑可能存在轻度 MPS(AMPS)。• 专家提出了一种诊断算法,详细重点关注 AMPS 儿童的生长速度下降、青春期延迟和关节活动受限,以缩短诊断和治疗时间,并有可能改善患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/b0c359d35da0/431_2019_3330_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/098102cf5d77/431_2019_3330_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/8420dc43aeb8/431_2019_3330_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/4eb44e459565/431_2019_3330_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/74b2248eeac5/431_2019_3330_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/b0c359d35da0/431_2019_3330_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/098102cf5d77/431_2019_3330_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/8420dc43aeb8/431_2019_3330_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/4eb44e459565/431_2019_3330_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/74b2248eeac5/431_2019_3330_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b59/6438949/b0c359d35da0/431_2019_3330_Fig5_HTML.jpg

相似文献

1
Growth impairment and limited range of joint motion in children should raise suspicion of an attenuated form of mucopolysaccharidosis: expert opinion.儿童生长障碍和关节运动范围受限应引起对黏多糖贮积症衰减形式的怀疑:专家意见。
Eur J Pediatr. 2019 Apr;178(4):593-603. doi: 10.1007/s00431-019-03330-x. Epub 2019 Feb 11.
2
Proposal of an Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS Ia) among Children with Growth Abnormalities.提出一种算法,以早期发现生长异常儿童中的 I 型黏多糖贮积症(MPS Ia)。
Medicina (Kaunas). 2022 Jan 8;58(1):97. doi: 10.3390/medicina58010097.
3
Functional capacity evaluation of patients with mucopolysaccharidosis.黏多糖贮积症患者的功能能力评估
J Pediatr Rehabil Med. 2012;5(1):37-46. doi: 10.3233/PRM-2012-0194.
4
Musculoskeletal manifestations of mucopolysaccharidoses.黏多糖贮积症的肌肉骨骼表现。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v19-25. doi: 10.1093/rheumatology/ker397.
5
Mucopolysaccharidoses.黏多糖贮积症。
Curr Rheumatol Rep. 2014 Jan;16(1):389. doi: 10.1007/s11926-013-0389-0.
6
Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.硫酸乙酰肝素和硫酸皮肤素衍生的二糖是黏多糖贮积症 I、II 和 III 型新生儿筛查的敏感标志物。
Mol Genet Metab. 2012 Dec;107(4):705-10. doi: 10.1016/j.ymgme.2012.09.024. Epub 2012 Sep 28.
7
Mucopolysaccharidoses: early diagnostic signs in infants and children.黏多糖贮积症:婴儿和儿童的早期诊断迹象。
Ital J Pediatr. 2018 Nov 16;44(Suppl 2):133. doi: 10.1186/s13052-018-0550-5.
8
Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis.关节挛缩在无炎症的情况下可能表明黏多糖贮积症。
Pediatr Rheumatol Online J. 2009 Oct 23;7:18. doi: 10.1186/1546-0096-7-18.
9
Growth impairment in mucopolysaccharidoses.黏多糖贮积症中的生长障碍。
Mol Genet Metab. 2018 May;124(1):1-10. doi: 10.1016/j.ymgme.2018.03.004. Epub 2018 Mar 16.
10
Diagnosis of the mucopolysaccharidoses.黏多糖贮积症的诊断。
Rheumatology (Oxford). 2011 Dec;50 Suppl 5:v41-8. doi: 10.1093/rheumatology/ker390.

引用本文的文献

1
Evaluation of tendon and ligament microstructure and mechanical properties in a canine model of mucopolysaccharidosis I.评估黏多糖贮积症 I 犬模型中的肌腱和韧带微观结构及力学性能。
J Orthop Res. 2024 Jul;42(7):1409-1419. doi: 10.1002/jor.25813. Epub 2024 Feb 18.
2
Capsular and retinaculum thickening in type II mucopolysaccharidosis: a novel MRI finding.Ⅱ型黏多糖贮积症的囊和腱增厚:一种新的 MRI 发现。
Skeletal Radiol. 2024 Jun;53(6):1211-1217. doi: 10.1007/s00256-023-04499-x. Epub 2023 Nov 6.
3
Proteomics identifies novel biomarkers of synovial joint disease in a canine model of mucopolysaccharidosis I.

本文引用的文献

1
Growth impairment in mucopolysaccharidoses.黏多糖贮积症中的生长障碍。
Mol Genet Metab. 2018 May;124(1):1-10. doi: 10.1016/j.ymgme.2018.03.004. Epub 2018 Mar 16.
2
Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome.未经移植的Hurler综合征患者接受酶替代疗法的长期认知和躯体结局
Mol Genet Metab Rep. 2017 Sep 27;13:64-68. doi: 10.1016/j.ymgmr.2017.07.012. eCollection 2017 Dec.
3
How should we investigate children with growth failure?我们应该如何对生长发育迟缓的儿童进行调查?
蛋白质组学鉴定黏多糖贮积症 I 犬模型中滑膜关节疾病的新型生物标志物。
Mol Genet Metab. 2023 Feb;138(2):107371. doi: 10.1016/j.ymgme.2023.107371. Epub 2023 Jan 4.
4
Mucopolysaccharidosis: What Pediatric Rheumatologists and Orthopedics Need to Know.黏多糖贮积症:儿科风湿病学家和骨科医生需要了解的内容。
Diagnostics (Basel). 2022 Dec 27;13(1):75. doi: 10.3390/diagnostics13010075.
5
Growth in individuals with attenuated mucopolysaccharidosis type I during untreated and treated periods: Data from the MPS I registry.黏多糖贮积症 I 型患者未经治疗和治疗期间的生长情况:来自 MPS I 登记处的数据。
Am J Med Genet A. 2022 Oct;188(10):2941-2951. doi: 10.1002/ajmg.a.62910. Epub 2022 Jul 23.
6
Proposal of an Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS Ia) among Children with Growth Abnormalities.提出一种算法,以早期发现生长异常儿童中的 I 型黏多糖贮积症(MPS Ia)。
Medicina (Kaunas). 2022 Jan 8;58(1):97. doi: 10.3390/medicina58010097.
7
Disease burden, management patterns and multidisciplinary clinical approaches for patients with MPS IVA and VI in selected Latin American Countries.拉丁美洲部分国家黏多糖贮积症IVA型和VI型患者的疾病负担、管理模式及多学科临床方法
Mol Genet Metab Rep. 2021 May 25;28:100769. doi: 10.1016/j.ymgmr.2021.100769. eCollection 2021 Sep.
8
Dental and maxillomandibular incidental findings in panoramic radiography among individuals with mucopolysaccharidosis: a cross-sectional study.多发性黏多糖贮积症个体全景放射片中的牙及颌面部偶发发现:一项横断面研究。
J Appl Oral Sci. 2021 Apr 14;29:e20200978. doi: 10.1590/1678-7757-2020-0978. eCollection 2021.
9
Clinical and genetic characteristics of concomitant Mucopolysaccharidosis type IVA and neurogenic bladder in children: two case reports and literature review.儿童同时患有黏多糖贮积症 IVA 型和神经源性膀胱的临床和遗传特征:两例病例报告及文献复习。
BMC Pediatr. 2021 Jan 6;21(1):18. doi: 10.1186/s12887-020-02484-0.
10
Home treatment of type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome) an alternative at this time of COVID-19 pandemic: A case in Peru.VI型黏多糖贮积症(马罗-拉米综合征)的居家治疗:在2019冠状病毒病大流行期间的一种选择——秘鲁的一个病例
Clin Case Rep. 2020 Oct 31;8(12):3483-3488. doi: 10.1002/ccr3.3420. eCollection 2020 Dec.
Ann Endocrinol (Paris). 2017 Jun;78(2):106-107. doi: 10.1016/j.ando.2017.04.008. Epub 2017 Apr 28.
4
Mucopolysaccharidoses seen in adults in rheumatology.风湿科中所见的黏多糖贮积症(Mucopolysaccharidoses)。
Joint Bone Spine. 2017 Dec;84(6):663-670. doi: 10.1016/j.jbspin.2017.01.008. Epub 2017 Feb 11.
5
Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I.I 型黏多糖贮积症患者用拉罗尼酶进行长期治疗的结果。
J Pediatr. 2016 Nov;178:219-226.e1. doi: 10.1016/j.jpeds.2016.08.033.
6
The diagnostic journey of patients with mucopolysaccharidosis I: A real-world survey of patient and physician experiences.黏多糖贮积症 I 型患者的诊断历程:患者及医生经历的真实世界调查
Mol Genet Metab Rep. 2016 Aug 2;8:67-73. doi: 10.1016/j.ymgmr.2016.07.006. eCollection 2016 Sep.
7
Neurodevelopmental Outcome after Hematopoietic Cell Transplantation in Inborn Errors of Metabolism: Current Considerations and Future Perspectives.先天性代谢缺陷患者造血细胞移植后的神经发育结局:当前考量与未来展望
Neuropediatrics. 2016 Oct;47(5):285-92. doi: 10.1055/s-0036-1584602. Epub 2016 Jun 16.
8
Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis.成人II型黏多糖贮积症患者的严重气管和支气管塌陷
Orphanet J Rare Dis. 2016 Apr 26;11:50. doi: 10.1186/s13023-016-0425-z.
9
Clinical course of sly syndrome (mucopolysaccharidosis type VII).斯利综合征(黏多糖贮积症VII型)的临床病程。
J Med Genet. 2016 Jun;53(6):403-18. doi: 10.1136/jmedgenet-2015-103322. Epub 2016 Feb 23.
10
The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS).亨特综合征患者生长发育的自然史:来自亨特结局调查(HOS)的数据。
Mol Genet Metab. 2016 Apr;117(4):438-46. doi: 10.1016/j.ymgme.2016.01.009. Epub 2016 Jan 25.